Global Blood Therapeutics announces proposed public offering of common stock
Global Blood Therapeutics announced an agreement to sell approximately $200.0 million in shares of its common stock in a registered underwritten public offering. GBT has granted underwriter a 30-day option to purchase up to approximately $30.0 million in shares of its common stock. June 25, 2019